trending Market Intelligence /marketintelligence/en/news-insights/trending/ewjls5puzt3abarluhk5uq2 content esgSubNav
In This List

Report: Aurobindo Pharma looking to buy Apotex's European business

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Report: Aurobindo Pharma looking to buy Apotex's European business

India's Aurobindo Pharma Ltd. is looking to buy the European business of privately held Apotex Inc. in a deal that could be valued at $100 million, The Economic Times reported.

The Canadian drugmaker is planning to divest its European business as part of a wider consolidation effort, the Indian newspaper reported citing industry sources.

Both Aurobindo and Apotex are manufacturers of generic drugs.